New COVID booster likely to become a yearly shot
The White House's COVID-19 Response Coordinator, Dr. Ashish Jha, announced that the FDA has approved updated versions of the Moderna and Pfizer-BioNTech vaccines that target both the original COVID virus and the two omicron subvariants currently causing the most infections.
During a COVID-19 Response Team press briefing on Tuesday at the White House, Jha described the boosters as "an important shift in our fight against the virus." The new boosters are available now.
NPR reports that COVID-19 vaccination will likely become a yearly vaccine similar to the flu vaccine. Also like the flu shot, the new vaccines can be adjusted every year to account for the dominant variants at the time. At the briefing, Jha called for people 12 and over to receive the vaccine. Dr. Anthony Fauci, also present at the press briefing, specified that some more vulnerable groups will likely still require more frequent boosters.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The new booster will continue to be free of charge for now, however, due to uncertainty regarding Congress providing more emergency funds, it is likely to be the last free booster for those without insurance. Data shows that COVID-19 cases, hospitalizations, and deaths have trended downward over the past month, but there are still approximately 70,000 new cases and upwards of 400 deaths per day.
"Get your updated COVID-19 shot as soon as you are eligible in order to protect yourself, your family, and your community against COVID-19 this fall and winter," urged Fauci.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
5 capitulating cartoons about the Democrat's shutdown surrenderCartoons Artists take on Democrat's folding, flag-waving, and more
-
How are these Epstein files so damaging to Trump?TODAY'S BIG QUESTION As Republicans and Democrats release dueling tranches of Epstein-related documents, the White House finds itself caught in a mess partially of its own making
-
Margaret Atwood’s memoir, intergenerational trauma and the fight to make spousal rape a crime: Welcome to November booksThe Week Recommends This month's new releases include ‘Book of Lives: A Memoir of Sorts’ by Margaret Atwood, ‘Cursed Daughters’ by Oyinkan Braithwaite and 'Without Consent' by Sarah Weinman
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
